Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: Technique, early toxicity, and PSA response

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 228-234

  Jabbari, Siavash ^a   Weinberg, Vivian K ^c   Kaprealian, Tania ^a   Hsu, I Chow ^a   Ma, Lijun ^a   Chuang, Cynthia ^a   Descovich, Martina ^a   Shiao, Stephen ^a   Shinohara, Katsuto ^b   Roach III, MacK ^a,b   Gottschalk, Alexander R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Prostate cancer; PSA nadir; Stereotactic body radiotherapy

Indexed keywords

ACUTE TOXICITY; ANDROGEN DEPRIVATION THERAPY; GASTROINTESTINAL TOXICITIES; HDR BRACHYTHERAPY; HIGH-DOSE-RATE BRACHYTHERAPY; MONO-THERAPY; PROSTATE CANCERS; PSA NADIR; SAN FRANCISCO; STEREOTACTIC BODY RADIOTHERAPY; UNIVERSITY OF CALIFORNIA;

DISEASES; DOSIMETRY; ONCOLOGY; TOXICITY;

RADIOTHERAPY;

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN; STEROID;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTERMETHOD COMPARISON; INTERMITTENT CATHETERIZATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; STEREOTACTIC BODY RADIATION THERAPY; UNITED STATES; URETHRAL CATHETERIZATION; URGE INCONTINENCE; URINARY TRACT DISEASE;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BRACHYTHERAPY; DOSE FRACTIONATION; FOLLOW-UP STUDIES; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; ORGANS AT RISK; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOSURGERY;

EID: 83955162970     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.026     Document Type: Article

References (49)

1. W.R. Lee The ethics of hypofractionation for prostate cancer Int J Radiat Oncol Biol Phys 73 2009 969 970
2. J.F. Fowler In reply to Dr. Lee Int J Radiat Oncol Biol Phys 74 2009 1332 1333
3. J.F. Fowler The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 44 2005 265 276
4. J.Z. Wang, X.A. Li, C.X. Yu, and S.J. DiBiase The low alpha/beta ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys 57 2003 1101 1108
5. J.Z. Wang, M. Guerrero, and X.A. Li How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55 2003 194 203
6. C. Cozzarini, C. Fiorino, and N. Di Muzio Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study Radiother Oncol 88 2008 26 33
7. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430
8. T.S. Lim, P.C. Cheung, and D.A. Loblaw Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: Acute toxicity results Int J Radiat Oncol Biol Phys 18 2008
9. V. Macias, and A. Biete Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials Clin Transl Oncol 11 2009 437 445
10. J.M. Martin, T. Rosewall, and A. Bayley Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma Int J Radiat Oncol Biol Phys 69 2007 1084 1089
11. E.F. Miles, and W.R. Lee Hypofractionation for prostate cancer: A critical review Semin Radiat Oncol 18 2008 41 47
12. T. Pawlicki, G.Y. Kim, and A. Hsu Investigation of linac-based image-guided hypofractionated prostate radiotherapy Med Dosim 32 2007 71 79
13. G.W. Wong, K.L. Palazzi-Churas, and D.F. Jarrard Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy Int J Radiat Oncol Biol Phys 70 2008 449 455
14. C. Vargas, A. Martinez, and R. Galalae High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features Prostate Cancer Prostatic Dis 9 2006 245 253
15. Holloway C, Hsu I-C, Albert M, Martin A, Suh W. Prostate Bracytherapy. In: Brachytherapy applications and techniques. Devlin P, editor. Philadelphia: Lippincott Williams and Wilkins; 2007;181-222.
16. I.S. Grills, A.A. Martinez, and M. Hollander High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds J Urol 171 2004 1098 1104
17. I.C. Hsu, A.R. Cabrera, and V. Weinberg Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer Brachytherapy 4 2005 202 206
18. A.A. Martinez, J. Demanes, and C. Vargas High-dose-rate prostate brachytherapy: An excellent accelerated-hypofractionated treatment for favorable prostate cancer Am J Clin Oncol 33 2010 481 488
19. C. Corner, A.M. Rojas, L. Bryant, P. Ostler, and P. Hoskin A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer Int J Radiat Oncol Biol Phys 72 2008 441 446
20. Y. Jo, H. Junichi, and F. Tomohiro Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: Effects on health-related quality of life BJU Int 96 2005 43 47
21. B.R. Pieters, D.Z. de Back, C.C. Koning, and A.H. Zwinderman Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review Radiother Oncol 93 2009 168 173
22. C.E. Vargas, A.A. Martinez, and T.P. Boike High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study Int J Radiat Oncol Biol Phys 66 2006 416 423
23. A.A. Martinez, I. Pataki, and G. Edmundson Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report Int J Radiat Oncol Biol Phys 49 2001 61 69
24. Kaprealian T, Weinberg V, Speight J, et al. High dose rate brachytherapy boost for prostate cancer: Comparison of two different fractionation schemes. Paper presented at the 2008 Annual Meeting of the American Society of Radiation Oncology (ASTRO); November 2008, Boston, MA.
25. P.J. Hoskin, K. Motohashi, and P. Bownes High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomised phase three trial Radiother Oncol 84 2007 114 120
26. I.C. Hsu, B. Kyounghwa, and K. Shinohara Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: Preliminary results of RTOG 0321 Int J Radiat Oncol Biol Phys 78 2010 751 758
27. Huang K CC, Hsu I, Gottschalk A, et al. Dosimetric comparison of Cyberknife radiosurgery versus inverse-planned high dose rate brachytherapy boost for prostate cancer. Paper presented at Cyberknife Users' Meeting, Carlsbad, CA, January 2006.
28. D.B. Fuller, J. Naitoh, and C. Lee Virtual HDR CyberKnife treatment for localized prostatic carcinoma: Dosimetry comparison with HDR brachytherapy and preliminary clinical observations Int J Radiat Oncol Biol Phys 70 2008 1588 1597
29. I.C. Hsu, E. Lessard, V. Weinberg, and J. Pouliot Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy Brachytherapy 3 2004 147 152
30. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327 333
31. M.E. Ray, H.D. Thames, and L.B. Levy PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis Int J Radiat Oncol Biol Phys. Mar 15 64 2006 1140 1150
32. P.D. Grimm, J.C. Blasko, and J.E. Sylvester 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
33. P. Alcantara, A. Hanlon, M.K. Buyyounouski, E.M. Horwitz, and A. Pollack Prostate-specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death Cancer 109 2007 41 47
34. J.M. Michalski, K. Bae, and M. Roach Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 Phase I/II dose escalation study Int J Radiat Oncol Biol Phys 76 2010 14 22
35. M.J. Zelefsky, H. Chan, and M. Hunt Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 2006 1415 1419
36. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
37. C.R. King, J.D. Brooks, and H. Gill Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective Phase II clinical trial Int J Radiat Oncol Biol Phys 73 2009 1043 1048
38. A.J. Katz, M. Santoro, and R. Ashley Stereotactic body radiotherapy for organ-confined prostate cancer BMC Urol 10 2010 1
39. J.L. Friedland, D.E. Freeman, M.E. Masterson-McGary, and D.M. Spellberg Stereotactic body radiotherapy: An emerging treatment approach for localized prostate cancer Technol Cancer Res Treat 8 2009 387 392
40. B.L. Madsen, R.A. Hsi, and H.T. Pham Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results Int J Radiat Oncol Biol Phys 15 67 2007 1099 1105
41. J.T. Wei, R.L. Dunn, and M.S. Litwin Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer Urology 20 56 2000 899 905
42. A. Trotti, A.D. Colevas, and A. Setser CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 2003 176 181
43. C. Rasch, I. Barillot, and P. Remeijer Definition of the prostate in CT and MRI: A multi-observer study Int J Radiat Oncol Biol Phys 43 1999 57 66
44. M. Roach 3rd, P. Faillace-Akazawa, and C. Malfatti Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 35 1996 1011 1018
45. Gottschalk AR, Hossain, S. Chuang, M., et al. Intrafraction prostate motion during Cyberknife radiosurgery: Implications on planning margins. Paper presented at the 50th Annual Meeting of the American Society for Radiation Oncology, September 2008, Boston, MA.
46. Y. Xie, D. Djajaputra, and C.R. King Intrafractional motion of the prostate during hypofractionated radiotherapy Int J Radiat Oncol Biol Phys 72 2008 236 246
47. S. Hossain, P. Xia, and C. Chuang Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT Med Phys 35 2008 4041 4048
48. M.H. Smitsmans, F.J. Pos, and J. de Bois The influence of a dietary protocol on cone beam CT-guided radiotherapy for prostate cancer patients Int J Radiat Oncol Biol Phys 71 2008 1279 1286
49. A.M. Nichol, P.R. Warde, and G.A. Lockwood A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion Int J Radiat Oncol Biol Phys 77 2010 1072 1078